Skip to Main content Skip to Navigation
Journal articles

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer

Abstract : Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine proteinase inhibitor that inhibits plasmin-dependent activation of several metalloproteinases. Downregulation of TFPI-2 could thus enhance the invasive potential of neoplastic cells in several cancers, including lung cancer. In this study, TFPI-2 mRNA was measured using a real-time PCR method in tumours of 59 patients with non-small-cell lung cancer (NSCLC). Tumour TFPI-2 mRNA levels appeared well correlated with protein expression evaluated by immunohistochemistry and were 4-120 times lower compared to those of nonaffected lung tissue in 22 cases (37%). Hypermethylation of the TFPI-2 gene promoter was demonstrated by restriction enzyme-polymerase chain reaction in 12 of 40 cases of NSCLC (30%), including nine of 17 for whom tumour TFPI-2 gene expression was lower than in noncancerous tissue. In contrast, this epigenetic modification was shown in only three of 23 tumours in which no decrease in TFPI-2 synthesis was found (P ¼ 0.016). Decreased TFPI-2 gene expression and hypermethylation were more frequently associated with stages III or IV NSCLC (eight out of 10, P ¼ 0.02) and the TFPI-2 gene promoter was more frequently hypermethylated in patients with lymph node metastases (eight out of 16, P ¼ 0.02). These results suggest that silencing of the TFPI-2 gene by hypermethylation might contribute to tumour progression in NSCLC.
Complete list of metadata

Cited literature [35 references]  Display  Hide  Download
Contributor : Florent HUBE Connect in order to contact the contributor
Submitted on : Monday, May 13, 2019 - 1:47:37 PM
Last modification on : Saturday, June 25, 2022 - 9:12:38 PM


10-2005-Brit J Cancer.pdf
Publisher files allowed on an open archive




J. Rollin, S Iochmann, C Bléchet, F Hubé, S. Regina, et al.. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. British Journal of Cancer, Cancer Research UK, 2005, 92 (4), pp.775-783. ⟨10.1038/sj.bjc.6602298⟩. ⟨hal-02127361⟩



Record views


Files downloads